Get startedLog in
    Picture of Terns Pharmaceuticals logo

    TERN — Terns Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapNeutral
    All News

    Brief: Terns Pharmaceuticals Presents Late-Breaking Data From Phase 2A Duet Trial

    Picture of Terns Pharmaceuticals logoTerns Pharmaceuticals
    13/11/2023 14:53
    Nov 13 (Reuters) - Terns Pharmaceuticals Inc  TERN.O :
    * TERNS PHARMACEUTICALS PRESENTS LATE-BREAKING DATA FROM
PHASE 2A
DUET TRIAL OF THR-Β AGONIST TERN-501 IN NASH AT AASLD THE LIVER
MEETING® 2023

Source text for Eikon:  ID:nGNX9y8db7 
Further company coverage:  TERN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Terns Pharmaceuticals

    See all news